| 12 Mon |
|---|
|
All-day
|
|
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
10:35 am
Invited Talk : Preclinical Outsourcing to India
@ Sathyam Hall
Invited Talk : Preclinical Outsourcing to India
@ Sathyam Hall
Aug 12 @ 10:35 am – 11:00 am
 Ganesh Sambasivam, Ph.D. CSO & Co-Founder, Anthem Biosciences India Preclinical Outsourcing to India The outsourcing segment is witnessing rapid changes with respect to the nature of work outsourced and the location. Cost is the major driver but other considerations such
11:42 am
Invited Talk: Osteoarthritis: diagnosis, treatment and challenges
@ Acharya Hall
Invited Talk: Osteoarthritis: diagnosis, treatment and challenges
@ Acharya Hall
Aug 12 @ 11:42 am – 12:07 pm
 Hideaki Nagase, Ph.D. Kennedy Institute of Rheumatology-Centre for Degenerative Diseases, University of Oxford, UK Osteoarthritis: diagnosis, treatment and challenges Hideaki Nagase1, Ngee Han Lim1, George Bou-Gharios1, Ernst Meinjohanns2 and Morten Meldal3 Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology
2:07 pm
Invited Talk: ColoAd1- An oncolytic adenovirus derived by directed evolution
@ Acharya Hall
Invited Talk: ColoAd1- An oncolytic adenovirus derived by directed evolution
@ Acharya Hall
Aug 12 @ 2:07 pm – 2:30 pm
 Terry Hermiston, Ph.D. Vice President, US Biologics Research Site Head, US Innovation Center Bayer Healthcare, USA ColoAd1 – An oncolytic adenovirus derived by directed evolution Attempts at developing oncolytic viruses have been primarily based on rational design. However, this approach
|
Subscribe to filtered calendar